Term
|
Definition
|
|
Term
Glyburide
1. Brand
2. Class |
|
Definition
1. Diabeta
2. Sulfonylurea |
|
|
Term
Glipizide
1. Brand
2. Class |
|
Definition
1. Glucotrol
2. Sulfonylurea |
|
|
Term
Glimepiride
1. Brand
2. Class |
|
Definition
1. Amaryl
2. Sulfonylurea |
|
|
Term
Repaglinide
1. Brand
2. Class |
|
Definition
|
|
Term
Nateglinide
1. Brand
2. Class |
|
Definition
|
|
Term
Pioglitazone
1. Brand
2. Class |
|
Definition
|
|
Term
Rosiglitazone
1. Brand
2. Class |
|
Definition
|
|
Term
Acarbose
1. Brand
2. Class |
|
Definition
1. Precose
2. a-glucosidase inhibitor |
|
|
Term
Miglitol
1. Brand
2. Class |
|
Definition
1. Glyset
2. a-glucosidase inhibitor |
|
|
Term
Sitagliptin
1. Brand
2. Class |
|
Definition
1. Januvia
2. DPP-4 inhibitor |
|
|
Term
Saxagliptin
1. Brand
2. Class |
|
Definition
1. Onglyza
2. DPP-4 inhibitor |
|
|
Term
Linagliptin
1. Brand
2. Class |
|
Definition
1. Tradgenta
2. DPP-4 Inhibitor |
|
|
Term
Colesevelam
1. Brand
2. Class |
|
Definition
1. Welchol
2. Bile acid sequestrant |
|
|
Term
Bromocriptine
1. Brand
2. Class |
|
Definition
1. Cycloset
2. DA-2 Agonist |
|
|
Term
Exenetide
1. Brand
2. Class |
|
Definition
1. Byetta
2. GLP-1 Agonists |
|
|
Term
Exenetide Extended Release
1. Brand
2. Class |
|
Definition
1. Bydureon
2. GLP-1 Agonist |
|
|
Term
Liraglutide
1. Brand
2. Class |
|
Definition
1. Victoza
2. GLP-1 Agonist |
|
|
Term
Pramlintide
1. Brand
2. Class |
|
Definition
1. Symlin
2. Amylin mimetic |
|
|
Term
Inslin lispro
1. Brand
2. Class |
|
Definition
1. Humalog
2. Rapid acting |
|
|
Term
Insulin Aspart
1. Brand
2. Class |
|
Definition
1. NovoLog
2. Rapid acting |
|
|
Term
Insuline Glulisine
1. Brand
2. Class |
|
Definition
1. Apidra
2. Rapid acting |
|
|
Term
2 short-acting (regular) inslins |
|
Definition
1. Humalin R
2. Novolin R |
|
|
Term
2 Intermediate (NPH) Insulins |
|
Definition
1. Humalin N
2. Novalin N |
|
|
Term
Insulin Glargine
1. Brand
2. Class |
|
Definition
1. Lantus
2. Long-acting (basal) insulin |
|
|
Term
Insulin Detemir
1. Brand
2. Class |
|
Definition
1. Levemir
2. Long-acting (basal) insulin |
|
|